Koji Ogawa

Title: Koji Ogawa: Innovator in Pharmaceutical Compounds

Introduction

Koji Ogawa is a notable inventor based in Tokyo-to, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of condensed polycyclic compounds. With a total of 4 patents to his name, Ogawa's work has the potential to impact various therapeutic areas.

Latest Patents

Ogawa's latest patents focus on condensed polycyclic compounds that serve as phosphodiesterase 4 inhibitors. These compounds are described in his inventions as novel and useful, with the potential for pharmaceutical applications. The patents detail the chemical structure of these compounds, which can also exist as pharmaceutically acceptable salts, along with compositions that incorporate them.

Career Highlights

Throughout his career, Koji Ogawa has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Mitsubishi Tanabe Pharma Corporation and Tanabe Seiyaku Company, Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ogawa has collaborated with several professionals in his field, including Tatsuzo Ukita and Yoshihiro Terakawa. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Koji Ogawa's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on condensed polycyclic compounds showcases the potential for advancements in therapeutic treatments.